home.aspx
 
EVENTS

Neuropharmacology 2019
NEUROPHARMACOLOGY 2019
September 20-21, 2019
A Neuropharmacology 2019 Summit is an opportunity to meet others within specialty to network and to learn the latest information from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, ...

Pharmacology and Toxicology 2019
PHARMACOLOGY AND TOXICOLOGY 2019
September 23-24, 2019
Toxicology-2019 will provide the excellent opportunity to meet experts, exchange information, and strengthen the collaboration among Directors, Researchers, Associate Professors, and Scholars from both academia and industry. At this gathering we provide a platform for the researchers, with new devel...

Vidyard

Vidyard is the video platform that helps businesses transform communications and drive more revenue through the strategic use of online video. Going beyond video hosting and management, we help businesses connect with more viewers through interactive and personalized video experiences, learn powerful insights on their viewing audience, turn insights into action with enterprise integrations, and prove the impact of their video programs.

RELATED NEWS


New figures from NHS Digital have revealed that pupils who have recently smoked, drunk alcohol and taken drugs are more likely to be unhappy. Specifically, 51 Percent of young people aged 11 to 15 who had recently drunk alcohol, smoked cigarettes and taken drugs reported experiencing low levels of happiness compared to 36 Percent who had recently done just one of these things, and 22% who hadn’t recently smoked, drank or taken drugs. The report, ‘Smoking, Drinking and Drug Use among ...

READ MORE

New computer models from North Carolina State University show how a variant of a common protein involved in human immune response binds to the antiviral drug abacavir, causing a severe life-threatening reaction known as the abacavir hypersensitivity syndrome (AHS). The work has implications for predicting severe adverse reactions caused by existing drugs and future drug candidates in subpopulations of patients....

READ MORE

Irish start-up Inflazome has won $1 million in funding from the Michael J. Fox Foundation (MJFF) to help it develop a brain imaging probe for Parkinson’s, as well as a new drug class for the disease. The cash injection will be used to support a positron emission tomography (PET) imaging technique that will help Inflazome bring forward small molecule drugs that target NLRP3, a protein complex or ‘inflammasome’ thought to be involved in harmful inflammatory processes in Parkinson...

READ MORE

Dementia refers to a series of neurodegenerative diseases, such as Alzheimer's, where a person's memory and other cognitive abilities decline. A recent study may have found a new risk factor that might predispose people to dementia: lung disease. According to the study by researchers from the University of Minnesota's School of Public Health in Minneapolis in collaboration with colleagues from other academic institutions in the United States, people who experience lung disease in mid...

READ MORE

Big Pharma has been able to count on China to jack up growth for the last several years, but in the second quarter one drugmaker Pfizers Upjohn unit wasnt so fortunate. Is that an ill omen for the rest of multinational pharma? One analyst is posing the question. During the second quarter, Pfizers Upjohn established medicine business now destined to merge with Mylan plummeted 20 Percent in China, mainly because of a volume-based procurement system under testing in 11 major Chinese cities. The pro...

READ MORE

As the opioid crisis continues in the United States, the U.S. Food and Drug Administration (FDA) has drafted new plans that will allow it to address past mistakes and “get ahead” of the situation that claims the lives of over 100 Americans per day. FDA Commissioner Scott Gottlieb said the agency has learned from past mistakes it, as well as other agencies made in order to stem the opioid crisis. In a statement issued Tuesday, Gottlieb said the FDA intends to “make sure that we&...

READ MORE

EVENTS

Neuropharmacology 2019
NEUROPHARMACOLOGY 2019
September 20-21, 2019
A Neuropharmacology 2019 Summit is an opportunity to meet others within specialty to network and to learn the latest information from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, ...

Pharmacology and Toxicology 2019
PHARMACOLOGY AND TOXICOLOGY 2019
September 23-24, 2019
Toxicology-2019 will provide the excellent opportunity to meet experts, exchange information, and strengthen the collaboration among Directors, Researchers, Associate Professors, and Scholars from both academia and industry. At this gathering we provide a platform for the researchers, with new devel...